Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Other Working Capital Changes: 2020-2025

Historic Other Working Capital Changes for Tango Therapeutics (TNGX) over the last 5 years, with Sep 2025 value amounting to -$53.8 million.

  • Tango Therapeutics' Other Working Capital Changes fell 363.65% to -$53.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.5 million, marking a year-over-year decrease of 112.58%. This contributed to the annual value of -$30.0 million for FY2024, which is 4.94% up from last year.
  • According to the latest figures from Q3 2025, Tango Therapeutics' Other Working Capital Changes is -$53.8 million, which was down 1,591.64% from -$3.2 million recorded in Q2 2025.
  • Tango Therapeutics' 5-year Other Working Capital Changes high stood at $16.4 million for Q2 2022, and its period low was -$53.8 million during Q3 2025.
  • In the last 3 years, Tango Therapeutics' Other Working Capital Changes had a median value of -$6.5 million in 2024 and averaged -$11.3 million.
  • As far as peak fluctuations go, Tango Therapeutics' Other Working Capital Changes spiked by 1,642.34% in 2021, and later slumped by 2,168.84% in 2022.
  • Over the past 5 years, Tango Therapeutics' Other Working Capital Changes (Quarterly) stood at -$3.7 million in 2021, then fell by 18.70% to -$4.4 million in 2022, then fell by 23.12% to -$5.4 million in 2023, then rose by 24.19% to -$4.1 million in 2024, then crashed by 363.65% to -$53.8 million in 2025.
  • Its last three reported values are -$53.8 million in Q3 2025, -$3.2 million for Q2 2025, and -$5.4 million during Q1 2025.